Avoid Ketorolac in This Patient
Do not give a ketorolac (Toradol) injection to this 76-year-old patient with GFR 52 mL/min. Ketorolac is contraindicated in patients with advanced renal impairment or at risk for renal failure 1, and this patient meets multiple high-risk criteria that make NSAID use particularly dangerous.
Why Ketorolac is Contraindicated Here
Your patient has three major risk factors that make ketorolac especially hazardous:
- Age >60 years - significantly increases risk of renal, GI, and cardiac toxicities 2
- GFR 52 mL/min - represents moderate renal impairment (Stage 3 CKD)
- Elderly with likely reduced renal reserve - decreased glomerular filtration rate with advancing age 3
The FDA label explicitly states ketorolac is contraindicated in patients with advanced renal impairment or at risk for renal failure 1. Multiple cancer pain guidelines identify age >60 years and compromised renal function as high-risk criteria requiring NSAID discontinuation 2. Case reports document acute renal failure in elderly patients after even brief ketorolac exposure 4, 5, and a 2025 study showed ketorolac in patients with CKD increased AKI incidence from 2.0% to 12.7% 6.
Recommended Treatment Algorithm for This Patient
First-Line: Acetaminophen
Start with acetaminophen 1000 mg orally every 6-8 hours (maximum 3-4 g/24 hours). Acetaminophen is recommended as first-line therapy for older adults with pain due to superior safety profile compared to NSAIDs 3. It's effective for low back pain with no significant renal, GI, or cardiovascular toxicity 3, 7.
Second-Line: Add Gabapentin for Radicular Component
Since you describe this as "sciatic" pain, add gabapentin starting at low dose (100-300 mg at bedtime, titrate up) if radicular symptoms are present. Gabapentin has fair evidence for small, short-term benefits in radiculopathy 7 and is safer in renal impairment with dose adjustment.
Third-Line: Short-Term Muscle Relaxant
If inadequate relief after 24-48 hours, consider adding a skeletal muscle relaxant (e.g., cyclobenzaprine 5 mg three times daily or methocarbamol 500-750 mg three times daily) for 3-5 days maximum. These provide moderate short-term pain relief for acute low back pain 8. Monitor for sedation and confusion in this elderly patient 3.
Fourth-Line: Tramadol if Severe Pain Persists
For severe pain uncontrolled by above measures, tramadol 50 mg every 6 hours as needed is an option. Tramadol has fair evidence for pain relief in low back pain 8 with lower abuse potential than traditional opioids, though still requires caution. Reduce dose by 50% in renal impairment.
Non-Pharmacologic Measures (Concurrent)
- Superficial heat application - good evidence for moderate benefits in acute low back pain 9
- Early mobilization as tolerated
- Consider spinal manipulation if symptoms persist beyond 48-72 hours - fair evidence for small to moderate benefits in acute low back pain 7
Critical Pitfalls to Avoid
Do not use any NSAID (including ibuprofen, naproxen, or COX-2 inhibitors) in this patient. While oral ibuprofen might seem "safer" than injectable ketorolac, all NSAIDs carry similar renal risks in elderly patients with CKD 2. The 2025 study showing comparable efficacy between oral ibuprofen and IM ketorolac 10 was conducted in younger patients (mean age 34.5 years) without renal impairment - not applicable here.
Avoid systemic corticosteroids - good evidence shows they are ineffective for low back pain with or without sciatica 7, 8.
Monitor renal function if you prescribe any medication with renal excretion (tramadol, gabapentin). Check BUN/creatinine if symptoms worsen or patient develops oliguria.
Expected Timeline
For acute sciatica (2 days duration), expect gradual improvement over 4-6 weeks with conservative management. Most patients with acute low back pain improve substantially within 4 weeks 7. If severe pain persists beyond 4-6 weeks or progressive neurologic deficits develop (foot drop, saddle anesthesia, bowel/bladder dysfunction), urgent imaging and specialist referral are indicated.
The combination of acetaminophen plus gabapentin (if radicular) plus short-term muscle relaxant provides multimodal analgesia without the prohibitive renal risks of ketorolac in this elderly patient with CKD.